SVP Worldwide Announces Global Launch of Three New PFAFF® Sewing Machines: creative expression™ 750, quilt expression™ 725, and expression™ 715
15.8.2025 01:33:00 EEST | Business Wire | Press release
SVP Worldwide, the parent company of PFAFF®, SINGER®, and HUSQVARNA® VIKING® sewing brands, today announced the highly anticipated global launch of three new PFAFF sewing machines: the creative expression 750, quilt expression 725, and expression 715. These machines combine precision engineering, cutting-edge technology, and the timeless craftsmanship PFAFF is known for.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814267636/en/
SVP Worldwide, the parent company of PFAFF (R), launches three new sewing machines: the creative expression 750, quilt expression 725 and expression 715. The machines combine precision engineering, cutting-edge technology, and the timeless craftsmanship PFAFF is known for globally.
The new models will be available for purchase beginning August 14, 2025 on PFAFF.com and at authorized PFAFF Dealer locations across the United States and Europe. Expanded global distribution in Latin America and Asia Pacific is planned throughout Q3 and Q4 of 2025.
"This launch represents an exciting new chapter for PFAFF and for passionate sewists around the world," said Rob Will, CEO of SVP Worldwide. "These three machines are designed to inspire creativity and confidence, offering the precision and innovation that our customers expect from the PFAFF brand. We can’t wait to see the extraordinary projects our ‘PFAFFies’ will bring to life with this new lineup."
The new expression series machines showcase advanced features tailored to both serious hobbyists and professional sewists. All models offer:
- Built-in connectivity to the CREATIVATE™ digital platform of creative tools
- Large color capacitive touch screens for an intuitive, modern sewing experience
- Automatic Needle Threaders eliminate threading frustration
- Exclusive PFAFF stitch techniques for distinctive embellishments
The creative expression 750 and quilt expression 725 also feature adjustable laser sewing guidance, enabling users to achieve unmatched accuracy for complex projects.
"The new PFAFF expression series brings together precision and innovation in a way that truly elevates the sewing experience," said Jason Zielke, Chief Product and Technology Officer at SVP Worldwide. "We are especially proud of the new Hoop Scanning feature on the creative expression 750, which allows a sewist to see their hooped project on the 8” color touch screen for a more accurate placement of the embroidery before stitching."
The launch of the PFAFF creative expression 750, quilt expression 725, and expression 715 reaffirms SVP Worldwide’s commitment to empowering creators worldwide with products that push the boundaries of sewing technology and innovation.
For more information or to locate a dealer, visit www.pfaff.com.
PFAFF, SINGER, VIKING, CREATIVE EXPRESSION, QUILT EXPRESSION, EXPRESSION and CREATIVATE are exclusive trademarks of Singer Sourcing Limited LLC or its Affiliates. HUSQVARNA and the “H” Crown Device are trademarks of Husqvarna AB and are used under license. © 2025 Singer Sourcing Limited LLC or its Affiliates. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250814267636/en/
Contacts
Media Inquiries:
Devon Smiddy
Sr. Director of Global Marketing, SVP Worldwide
devon.smiddy@svpworldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Frasca Pilatus PC-12 PRO Flight Training Device Receives FOCA Qualification21.4.2026 17:05:00 EEST | Press release
Frasca International, Inc., a FlightSafety International company and global leader in flight simulation, today announced that its Pilatus PC-12 PRO Flight Simulation Training Device (FSTD) received Level 2 Flight Training Device (FTD2) and Flight and Navigation Procedures Trainer (FNPT II) qualification from Switzerland’s Federal Office of Civil Aviation (FOCA). Frasca is the first to develop a PC-12 PRO training device. The device equipped with Garmin’s G3000 PRIME Avionics suite is installed at Pilatus Aircraft Ltd headquarters in Stans, Switzerland, where it will support training for the next generation of PC-12 pilots. The qualification enables pilots to complete a wide range of instruments, procedural and advanced systems training in a highly immersive environment that mirrors the capabilities of the aircraft. “The PC-12 PRO leads the way with advanced features, and we’re proud to produce a state-of-the-art simulator that allows pilots to seamlessly transition from the FTD to the
Frasca Pilatus PC-12 PRO Flight Training Device Receives FOCA Qualification21.4.2026 17:05:00 EEST | Press release
Frasca International, Inc., a FlightSafety International company and global leader in flight simulation, today announced that its Pilatus PC-12 PRO Flight Simulation Training Device (FSTD) received Level 2 Flight Training Device (FTD2) and Flight and Navigation Procedures Trainer (FNPT II) qualification from Switzerland’s Federal Office of Civil Aviation (FOCA). Frasca is the first to develop a PC-12 PRO training device. The device equipped with Garmin’s G3000 PRIME Avionics suite is installed at Pilatus Aircraft Ltd headquarters in Stans, Switzerland, where it will support training for the next generation of PC-12 pilots. The qualification enables pilots to complete a wide range of instruments, procedural and advanced systems training in a highly immersive environment that mirrors the capabilities of the aircraft. “The PC-12 PRO leads the way with advanced features, and we’re proud to produce a state-of-the-art simulator that allows pilots to seamlessly transition from the FTD to the
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting21.4.2026 17:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that full results from the Phase 3 pivotal study evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) will be featured as an oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2026, in Chicago. “The positive Phase 3 frontMIND results for tafasitamab in patients with newly diagnosed diffuse large B-cell lymphoma highlight Incyte’s continued focus on advancing novel differentiated approaches with the potential to meaningfully impact patients,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “We look forward to sharing the full data at ASCO, and to progressing our pipeline.” Presentation details: frontMIND: Phase 3 Study of tafasitamab (Tafa) Plus lenalidomide (Len) and R-CHOP for Patients (pts) with Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) (Abstract #7000. Session: Oral Abstract Session
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting21.4.2026 17:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that full results from the Phase 3 pivotal study evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) will be featured as an oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2026, in Chicago. “The positive Phase 3 frontMIND results for tafasitamab in patients with newly diagnosed diffuse large B-cell lymphoma highlight Incyte’s continued focus on advancing novel differentiated approaches with the potential to meaningfully impact patients,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “We look forward to sharing the full data at ASCO, and to progressing our pipeline.” Presentation details: frontMIND: Phase 3 Study of tafasitamab (Tafa) Plus lenalidomide (Len) and R-CHOP for Patients (pts) with Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) (Abstract #7000. Session: Oral Abstract Session
Andersen Global Strengthens West Africa Platform with the Addition of Member Firm in Ghana21.4.2026 16:30:00 EEST | Press release
Andersen Global continues its expansion across Africa, with Lima Partners joining as a member firm and introducing the Andersen name in Ghana. Established in 2014 and headquartered in Accra, Andersen in Ghana is led by Managing Partner Daniel Addo Okoe. The firm provides a full range of professional services, including tax advisory, regulatory compliance, accounting and advisory, transfer pricing, payroll administration, immigration, and company secretarial services to both local and international clients operating in Ghana and the wider West African region. “Becoming a member firm of Andersen Global marks a significant milestone for our organization,” said Kwame Amporful, senior partner of Andersen in Ghana. “Our clients will benefit from enhanced cross-border capabilities while continuing to receive practical, high-quality advisory services tailored to the Ghanaian market.” “Ghana plays a vital role in facilitating cross-border trade and investment within West Africa,” added Mark L.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom